Carelane, a Bremen, Germany-based life sciences technology startup, raised €800K in Pre-Seed funding.
The round was led by High-Tech Gründerfonds (HTGF).
The company intends to use the funds to accelerate the expansion of its unified platform designed to streamline clinical trials, reducing the operational burdens faced by pharmaceutical companies, contract research organizations, and academic researchers.
Founded by Gustav Vella and Yannick Boerner, Carelane is a health tech startup focused on addressing the inefficiencies in clinical trials by integrating multiple essential functions into a single, streamlined system, thereby digitizing study protocols and processes. With Carelane, study protocols are structured, digitized documents rather than text-based, enabling integration and continuous alignment of study design, conduct, and analysis.
The platform enhances security using the latest cloud technologies but also includes features for managing common trial processes such as sample shipments, site onboarding, and patient consents. All of this is achieved while maintaining a unified audit trail.
FinSMEs
27/06/2024